ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 99.00K | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | -- | 36.48M | 37.48M | 39.67M | 46.74M | 53.36M | |
| R&D | -- | 26.32M | 31.29M | 32.32M | 36.23M | 42.12M | |
| SG&A | -- | 10.16M | 6.19M | 7.35M | 10.51M | 11.24M | |
| Operating Income | -- | -36.38M | -37.48M | -39.67M | -46.74M | -53.36M | |
| EBITDA | -- | -34.33M | -33.39M | -37.02M | -51.73M | -51.99M | |
| Pretax Income | -- | -35.52M | -34.56M | -38.20M | -52.80M | -53.01M | |
| Income Tax | -- | -56.00K | -1.04M | 63.00K | -8.00K | 49.00K | |
| Net Income | -- | -35.46M | -33.52M | -38.26M | -52.79M | -53.06M | |
| EPS Diluted | -1.50 | -0.75 | -- | -0.81 | -1.74 | -1.10 | |
| Diluted Shares | 27.56M | 47.17M | -- | 47.17M | 30.28M | 48.02M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--